Published by
@ShahidNShah
@ShahidNShah
GSR Ventures Survey: Digital Health Investors Believe ROI and Clinical Validation Will be the Greatest Markers of Success in 2023
According to a recent survey of leading digital health investors conducted by GSR Ventures, investors in the healthcare technology sector believe that a quantifiable return on investment (ROI) and clinical validation of the technology's platform will be the most important indicators of company success in 2023. More than 94% of investor respondents rated ROI as "essential" or "extremely important," and 79% said the same about clinical data and trials. According to Dr. Sunny Kumar, a Partner with GSR Ventures, "Generating a high ROI has always been crucial for health IT businesses and we're seeing that even more stressed in the present environment as purchasers prioritise their spending on products with the strongest value proposition." However, we were most thrilled to see the majority.
Continue reading at prnewswire.com
Make faster decisions with community advice
- New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management
- Patients With Heart and Lung Disease Are More Likely to Follow Medication Therapy When They Participate in a Mobile Integrated Healthcare Program
- Stericycle's Second Annual Healthcare Workplace Safety Trend Report Reveals Perspectives and Insights for Improving Patient and Provider Safety
- Top 8 Most Controversial Stories About Medical Innovations
- To Truly Address Behavioral Health Worker Shortages, We Need Telemedicine
Next Article
-
New Report from BluesightⓇ Sheds Light on U.S. Consumer Trust in Healthcare and Pharmaceutical Management
The Medication IntelligenceTM Company, BluesightR, today released the findings of a recent survey evaluating American consumers' trust in the country's healthcare system and pharmaceutical sector, …
Posted Dec 17, 2022 Technology, Pharmaceutical
